鹿児島大学大学院 医歯学総合研究科 心臓血管・高血圧内科学

Facebook

Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University

研究について

臨床研究:業績

【2016】原著(英文)

  • Oketani N, Seitz J, Salazar M, Pisapia A, Kalifa J, Smit JJ, Nademanee K.
  • Ablation of complex fractionated electrograms is useful for catheter ablation of persistent atrial fibrillation: protagonist point of view.
    Heart Rhythm 2016; 13: 2098-2100.
  • Chaen H, Kinchiku S, Miyata M, Kajiya S, Uenomachi H, Yuasa T, Takasaki K, Ohishi M.
  • The validity of a novel method for estimating low-density lipoprotein cholesterol levels in diabetic patients.
    J Atheroscler Thromb 2016; 23: 1355-1364.
  • Yoshino S, Cilluffo R, Prasad M, Best PJ, Atkinson EJ, Aoki T, Cunningham J, de Andrade M, Lerman LO, Lerman A.
  • Sex-specific genetic variants are associated with coronary endothelial dysfunction.
    J Am Heart Assoc 2016; 5: e002544.
  • Kawasoe S, Kubozono T, Yoshifuku S, Ojima S, Oketani N, Miyata M, Miyahara H, Maenohara S, Ohishi M.
  • Uric acid level and prevalence of atrial fibrillation in 285,882 Japanese general population.
    Cir J 2016; 80: 2453-2459.
  • Kanda D, Takumi T, Miyata M, Tokushige A, Sonoda T, Yoshino S, Saihara K, Ohishi M.
  • Angiotensin-converting enzyme inhibitor prevents the worsening of renal function in the late phase after percutaneous coronary intervention.
    J Atheroscler Thromb 2016; 23: 233-240.
  • Fukunaga K, Kajiya T, Takaoka J, Arima R, Miyamura A, Atsuchi N, Atsuchi Y, Yamaguchi H, Ohishi M.
  • Smooth arterial healing after paclitaxel-coated balloon angioplasty for in-stent restenosis assessed by optical frequency domain imaging.
    Asia Intervention 2016; 2: 44-47.
  • Tei C, Imamura T, Kinugawa K, Inoue T, Masuyama T, Inoue H, Noike H, Muramatsu T, Takeishi Y, Saku K, Harada K, Daida H, Kobayashi Y, Hagiwara N, Nagayama M, Momomura S, Yonezawa K, Ito H, Gojo S, Akaishi M, Miyata M, Ohishi M, WAON-CHF Study Investigators.
  • Waon therapy for managing chronic heart failure: results from a multicenter prospective randomized WAON-CHF study.
    Circ J 2016; 80: 827-834.
  • Maekawa Y, Sugimoto K, Yamazaki M, Takeya Y, Yamamoto K, Ohishi M, Ogihara T, Shintani A, Doki Y, Mori M, Rakugi H.
  • Comprehensive geriatric assessment (CGA) is a useful predictive tool for understanding the development of postoperative delirium (POD) after gastrointestinal surgery in old-old adults.
    Geriatr Gerontol Int 2016; 16: 1036-1042.
  • Hiroi S, Shimasaki Y, Kikuchi T, Otsuka Y, Iasaki K, Ohishi M.
  • Analysis of second- and third-line antihypertensive treatments after initial therapy with an angiotensin II receptor blocker using real-world Japanese data.
    Hypertens Res 2016; 39: 907-912.
  • Tanaka A, Murohara T, Taguchi I, Eguchi K, Suzuki M, Kitakaze M, Sato Y, Ishizu T, Higashi Y, Yamada H, Nanasato M, Shimabukuro M, Teragawa H, Ueda S, Kodera S, Matsuhisa M, Kadokami T, Kario K, Nishio Y, Inoue T, Maemura K, Oyama J, Ohishi M, Sata M, Tomiyama H, Node K; PROTECT Study Investigators.
  • Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT study.
    Cardiovasc Diabetol 2016; 15: 133.
  • Oyama J, Tanaka A, Sato Y, Tomiyama H, Sata M, Ishizu T, Taguchi I, Kuroyanagi T, Teragawa H, Ishizaka N, Kanzaki Y, Ohishi M, Eguchi K, Higashi Y, Yamada H, Maemura K, Ako J, Bando YK, Ueda S, Inoue T, Murohara T, Node K; PRIZE Study Investigators.
  • Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE study.
    Cardiovasc Diabetol 2016; 15: 87.
  • Tokito A, Jougasaki M.
  • Matrix metalloproteinases in non-neoplastic disorders.
    Int J Mol Sci 2016; 17: E1178.
  • Shirakabe A, Ikeda Y, Sciarretta S, Zablocki DK, Sadoshima J.
  • Aging and autophagy in the heart.
    Circ Res 2016; 118: 1563-1576.
  • Shirakabe A, Zhai P, Ikeda Y, Saito T, Maejima Y, Hsu CP, Nomura M, Egashira K, Levine B, Sadoshima J.
  • Drp1-dependent mitochondrial autophagy plays a protective role against pressure overload-induced mitochondrial dysfunction and heart failure.
    Circulation 2016; 133: 1249-1263.
  • Lee CYW, Huntley BK, McCormick DJ, Ichiki T, Sangaralingham SJ, Lisy O, Burnett JC Jr.
  • Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions.
    Eur Heart J Cardiovasc Pharmacother 2016; 2: 98-105.
  • Sangaralingham SJ, Wang BH, Huang L, Kumfu S, Ichiki T, Krum H, Burnett JC Jr.
  • Cardiorenal fibrosis and dysfunction in aging: imbalance in mediators and regulators of collagen.
    Peptides. 2016; 76: 108-114.
  • Pravenec M, Kozich V, Krijt J, Sokolova J, Zidek V, Landa V, Mlejnek P, Silhavy J, Simakova M, Skop V, Trnovska J, Kazdova L, Kajiya T, Wang J, Kurtz TW.
  • Genetic variation in renal expression of folr1 (folate receptor 1) gene predisposes spontaneously hypertensive rats to metabolic syndrome.
    Hypertension 2016; 67: 335-341.
  • Yoshimura A, Iriki Y, Ichiki H, Oketani N, Okui H, Maenosono R, Namino F, Miyata M, Ohishi M.
  • Evaluation of safety and efficacy of periprocedural use of rivaroxaban and apixaban in catheter ablation for atrial fibrillation.
    J Cardiol (Epub ahead of print)
  • Ando K, Ishii K, Tada E, Kataoka K, Hirohata A, Goto K, Kobayashi K, Tsutsui H, Nakahama M, Nakashima H, Uchikawa S, Kanda J, Yasuda S, Yajima J, Kitabayashi H, Sakurai S, Nakanishi K, Inoue N, Noike H, Hasebe T, Sato T, Yamasaki M, Kimura T.
  • Prospective multi-center registry to evaluate efficacy and safety of the newly developed diamond-like carbon-coated cobalt-chromium coronary stent system.
    Cardiovascular Intervention and Therapeutics (Epub ahead of print)
  • Kubo T, Ochi Y, Baba Y, Hirota T, Tanioka K, Yamasaki N, Yoshimitsu M, Higuchi K, Takenaka T, Nakajima K, Togawa T, Tsukimura T, Sano S, Tei C, Sakuraba H, Kitaoka H.
  • Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy.
    J Cardiol (Epub ahead of print)
  • Kuwahata S, Takenaka T, Yasuda S, Sakoda T, Taniyama H, Nagata Y, Iwakawa J, Matsumoto S, Seto T, Takenoyama M, Abe S, Ohishi M.
  • A case of anticoagulant treatment-resistant Trousseau syndrome controlled by treatment of the underlying lung adenocarcinoma: utility of monitoring D-dimer levels.
    J Cardiol Cases (in press)
  • Kajiya T, Takaoka J, Atsuchi N, Atsuchi Y, Ohishi M.
  • Unroofed coronary sinus with cardiac veins.
    Acta Cardiol (in press)
  • 昨年度追加分
  • Ohno S, Miyata M, Kohjitani A, Tohya A, Ohishi M, Sugiyama K.
  • Associations between blood pressure responses to acute stress and impaired renal function and serum uric acid level.
    Clin Exp Hypertens 2015; 37: 656-660.
  • Daitoku S, Yuasa T, Tsunenari H, Maenohara S, Mine K, Tamatsu Y, Shimada K, Koriyama C, Ohishi M, Horiuchi M.
  • Angle between the common and internal carotid arteries detected by ultrasound is related to intima-media thickness among those with atherosclerotic disease.
    Environ Health Prev Med 2015; 20: 216-223.
  • Arima R, Yamaguchi H, Takaoka J, Miyamura A, Atsuchi N, Ninomiya T, Atsuchi Y, Ohishi M, Terashima M, Kaneda H.
  • Simple balloon dilation for drug-eluting in-stent restenosis: an optical coherent tomography analysis.
    Cardiovasc Revasc Med 2015; 16: 27-31.
  • Yamaguchi H, Arikawa R, Takaoka J, Miyamura A, Atsuchi N, Ninomiya T, Atsuchi Y, Ohishi M, Terashima M, Kaneda H.
  • Association of morphologic characteristics on optical coherence tomography and angiographic progression patterns of late restenosis after drug-eluting stent implantation.
    Cardiovasc Revasc Med 2015; 16: 32-35.
  • Tokito A, Koriyama N, Ijuin A, Ogiso K, Nishio Y, Jougasaki M.
  • Switching from sitagliptin to alogliptin under treatment with pioglitazone increases high-molecular weight adiponectin in type 2 diabetes: a prospective observational study.
    J Diabetes Mellitus. 2015; 5: 258-266.
  • Kyrychenko S, Kyrychenko V, Badr MA, Ikeda Y, Sadoshima J, Shirokova N.
  • Pivotal role of miR-448 in the development of ROS-induced cardiomyopathy.
    Cardiovasc Res 2015; 108: 324-334.
  • Oka SI, Zhai P, Yamamoto T, Ikeda Y, Byun J, Hsu CP, Sadoshima J.
  • PPARα association with sirt1 suppresses cardiac fatty acid metabolism in the failing heart.
    Circ Heart Fail 2015; 8: 1123-1132.